Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.

Shivali BereraStephanie C IoannouDiana MorilloAlejandro M A Mantero Judith Pignac-KobingerNiurka ColinaAna M SantanderIrina FernandezMaria Alejandra QuinteroJennifer RodriguezDavid H KermanOriana M DamasFrank CzulDaniel A SussmanMaria T AbreuAmar R Deshpande

Published in: Journal of Crohn's & colitis (2022)

VDZ/PTX did not provide benefit over VDZ monotherapy in clinical or endoscopic remission but appeared to improve clinical response and was safe. These data should inform a fully powered study.

Keyphrases

placebo controlled
double blind
open label
clinical trial
ulcerative colitis
rheumatoid arthritis
electronic health record
big data
machine learning
disease activity
phase ii
deep learning
rectal cancer
patients with inflammatory bowel disease